M&A Deal Summary |
|
---|---|
Date | 2021-08-11 |
Target | Healthcare Components Group |
Sector | Medical Products |
Buyer(s) | RoundTable Healthcare Management |
Deal Type | Consolidation |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 2001 |
PE ASSETS | 2.9B USD |
Size | Large |
Type | Sector Focused |
RoundTable Healthcare Partners is a specialist private equity firm that targets equity and junior capital investments in the healthcare industry. Specific areas of interest include medical devices, medical products and disposables, specialty pharmaceuticals, medication delivery systems, specialty distribution, and outsourced healthcare services. RoundTable typically makes equity investments of approximately $5 to $50 million in platform companies with revenues ranging from $25 to $300 million. RoundTable will not invest in service-oriented provider segments (such as managed care companies, hospitals or nursing homes), internet or biotechnology companies, or start-up/venture situations. RoundTable was formed in 2001 and is based in Lake Forest, Illinois.
DEAL STATS | # |
---|---|
Overall | 27 of 31 |
Sector (Medical Products) | 14 of 14 |
Type (Consolidation) | 2 of 2 |
State (Missouri) | 1 of 1 |
Country (United States) | 26 of 30 |
Year (2021) | 3 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-08-01 |
Acumen Health Holdings
Blue Bell, Pennsylvania, United States Acumen Health Holdings owns a portfolio of companies that specialize in providing physicians and veterinarians clinically researched products to recommend and dispense to their patients using Acumen’s proprietary subscription-based platform. Acumen Health Holdings is based in Blue Bell, Pennsylvania. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-11-02 |
Deerland Probiotics & Enzymes
Kennesaw, Georgia, United States Deerland Probiotics & Enzymes is a developer, formulator, and manufacturer of enzyme- and probiotic-based dietary supplements. Deerland specializes in customized product formulations and offers a line of clinically-studied branded ingredients, including its probiotic, DE111, which recently earned Non-GMO Project verification and Health Canada approval. The Company also offers multiple branded enzymes, including its innovative Glutalytic and ProHydrolase products. Deerland Enzymes was founded in 1990 and is based in Kennesaw, Georgia. |
Sell | - |